Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement
23:15 EDT 17 Jun 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
LAUSANNE, Switzerland, and SUZHOU, China, June 18, 2012 /PRNewswire-Asia/ -- Debiopharm Group™ (Debiopharm), a global biopharmaceutical development specialist that focuses on serious medical conditions and particularly oncology, and Asce...
Other Sources for this Article
More From BioPortfolio on "Debiopharm and Ascepion Pharmaceuticals, Inc. Announce Exclusive License Agreement"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
